2019-11-06T09:37:11-08:00 2019-06-30 352317502 Bunker & Company LLP 4340 Redwood Hwy Suite 117 San Rafael CA 949032123 990 2018-07-01 942495035 GLAUCOMA RESEARCH FOUNDATION GLAU 4159863162 251 POST STREET STE 600 SAN FRANCISCO CA 94108 THOMAS M BRUNNER President & CEO 2019-11-06 true JOSEPH C BUNKER P00204452 4154997661 2018 2020-01-14 16:20:31Z THOMAS M BRUNNER 251 POST STREET STE 600 SAN FRANCISCO CA 94108 3673845 false false X www.glaucoma.org X 1978 CA Cure Glaucoma and restore vision through innovative research. 13 12 9 25 0 3729663 1872259 371263 602319 525016 586444 423010 318907 5048952 3379929 1100417 1395428 0 1124977 1312582 0 480098 1437253 1363695 3662647 4071705 1386305 -691776 11586601 10976910 575290 728352 11011311 10248558 Cure Glaucoma and restore vision through innovative research. false false 3350390 THE ORGANIZATION PROMOTES AND SUPPORTS RESEARCH AND EDUCATION CONCERNING THE CAUSES AND TREATMENT OF GLAUCOMA. IT HAS BEEN A LEADER IN COLLABORATIVE RESEARCH THROUGH THE LANDMARK MULTI-CENTER NORMAL TENSION GLAUCOMA STUDY WHICH TRANSFORMED GLAUCOMA TREATMENT, AS WELL AS THE CREATION OF THE "CATALYST FOR A CURE" (CFC). THIS UNIQUE RESEARCH MODEL BRINGS TOGETHER SCIENTISTS FROM DIFFERENT DISCIPLINES TO WORK TOGETHER TO UNDERSTAND GLAUCOMA AND FIND WAYS TO IMPROVE TREATMENT AND FIND A CURE. THE FIRST CFC TEAM MADE A SIGNIFICANT IMPACT ON THE FIELD OF GLAUCOMA AND HELPED TO TRANSFORM THE UNDERSTANDING OF GLAUCOMA FROM AN EYE DISEASE TO A NEURODEGENERATIVE DISEASE.TAKING THE FINDINGS FROM THE FIRST TEAM, A SECOND CFC TEAM WAS CREATED TO DEVELOP NEW BIOMARKERS TO DIAGNOSE AND MANAGE GLAUCOMA MORE EFFECTIVELY BEFORE VISION IS LOST AND OPEN PATHWAYS TO NEW TREATMENT OPTIONS FOR PATIENTS. A third CFC Team was launched in January to discover ways to restore vision lost to glaucoma by restoring, regenerating or replacing the retinal ganglion cells damaged in glaucoma.THE ORGANIZATION ALSO PROVIDES FUNDING FOR INNOVATIVE PILOT STUDIES IN GLAUCOMA RESEARCH. THESE INCUBATOR GRANTS ENABLE SCIENTISTS TO INVESTIGATE A NOVEL AND PROMISING IDEA AND GATHER CRITICAL DATA TO CONTINUE THEIR RESEARCH AND SECURE ADDITIONAL FUNDING. THIS PROGRAM CONTINUES TO NURTURE THE CAREERS OF PROMISING GLAUCOMA INVESTIGATORS AND BRING NEW IDEAS TO THE FIELD OF GLAUCOMA RESEARCH. IN ADDITION, THE ORGANIZATION SERVES AS A PRIMARY SOURCE OF INFORMATION AND SUPPORT FOR PATIENTS BY PROVIDING UNBIASED EDUCATIONAL MATERIALS IN PRINT AND ONLINE. 3350390 true true false false false false false false false true true false false true false false true false false false true true false false true false false true false true false false false false false false false false false false false true false false false false false false false false true 20 0 true 9 true false false false false false false true true false 0 false false false false false false false false false false false false X 13 12 false false false false false false false true true false false true true true true true true true true false CA X X X GLAUCOMA RESEARCH FOUNDATION 4159863162 251 POST ST 600 SAN FRANCISCO CA 94108 ANDREW G IWACH MD CHAIR 2.00 0.00 X X 0 0 0 THOMAS M BRUNNER President & CEO 32.00 0.00 X X 241697 0 12085 RUTH D WILLIAMS MD VICE CHAIR 2.00 0.00 X X 0 0 0 CHARLES R WILMOTH Treasurer 2.00 0.00 X X 0 0 0 RICK HALPRIN CPA Secretary 2.00 0.00 X X 0 0 0 FREDERICK H BRINKMANN Director 2.00 0.00 X 0 0 0 Martin B Wax MD Director 2.00 0.00 X 0 0 0 MONICA L VETTER PHD Director 2.00 0.00 X 0 0 0 ROBERT L STAMPER MD Director 2.00 0.00 X 0 0 0 DENNIS E SINGLETON Director 2.00 0.00 X 0 0 0 LINDA C LINCK Director 2.00 0.00 X 0 0 0 ADRIENNE L GRAVES PHD Director 2.00 0.00 X 0 0 0 John G Flanagan PHD Director 2.00 0.00 X 0 0 0 NANCY GRAYDON E.D. DEVEL. & COO 40.00 0.00 X 212800 0 9531 CATALINA SAN AGUSTIN DIRECTOR OPERATION 40.00 0.00 X 132542 0 5302 ANDREW JACKSON DIR. COMMUNICATION 40.00 0.00 X 128510 0 2570 715549 29488 4 false true false Cathy Leiden Elsewhere 4121 Radford Ave Studio City CA 91604 Graphic Design 105755 Jacqueline Jones Design 346 G St San Rafael CA 94901 Graphic Design 123268 2 1872259 39562 1872259 CONFERENCE/FORUM 602319 602319 602319 586635 586635 0 0 0 -191 -191 -191 -191 590720 293916 296804 296804 0 0 MISCELLANEOUS 22103 22103 22103 3379929 624422 883248 1256830 1256830 0 138598 138598 0 253782 215715 19033 19034 0 1058800 787283 87172 184345 0 0 0 0 0 0 0 0 0 0 0 0 0 0 158477 120558 12937 24982 0 0 0 0 0 0 0 OTHER EXPENSES 473738 377448 4215 92075 OPERATING EXPENSES 422577 272856 17526 132195 CONSULTING EXPENSES 308903 181102 100334 27467 0 4071705 3350390 241217 480098 389215 219220 646103 419508 1116149 846264 0 0 0 0 25101 34265 99180 134475 102350 61055 14670 41295 5790015 5770989 0 0 0 3506168 3510894 11586601 10976910 134040 147102 441250 581250 575290 728352 X 4711069 4007922 2957742 2898136 3342500 3342500 11011311 10248558 11586601 10976910 X -691776 -81052 10075 X false true X true false X 2912057 3121339 3230442 3729663 1872259 14865760 0 0 2912057 3121339 3230442 3729663 1872259 14865760 2980504 11885256 302156 375116 262504 403695 586635 1930106 0 314222 221361 404449 423010 318907 1681949 18477815 2040600 0.64320 0.64470 X 3342500 3342500 3342500 3342500 3342500 3342500 3342500 3342500 3300000 42500 3342500 1.00000 false false false 3363 3363 98987 57692 41295 41295 ASSETS HELD IN TRUST - MUTUAL FUNDS 168394 PERMANENTLY RESTRICTED INVESTMENTS 3342500 3510894 3298877 -81052 -81052 3379929 3379929 4071705 4071705 4071705 Part V, Line 4: Intended uses of the endowment fund. Permanently restricted funds are allocated as: Annual Research Grant, $800,000;Research and Annual Sutro Lecture, $2,542,000.THE ANNUAL INCOME FROM "THE DR. HENRY A. SUTRO FAMILY GRANT FOR RESEARCH" WILL BE USED FOR SPECIAL INVESTIGATIONS.THE ANNUAL INCOME FROM $1,000,000 OF THE ENDOWMENT WILL BE USED FOR THE "DRS. HENRY AND FREDERICK SUTRO MEMORIAL LECTURE" true Europe 0 0 Grants for RESEARCH 62098 Asia 0 0 Grants for RESEARCH 25000 North America 0 0 Grants for RESEARCH 51500 138598 138598 Asia GLAUCOMA RESEARCH 25000 Wiretransfer Europe GLAUCOMA RESEARCH 62098 Wiretransfer North America GLAUCOMA RESEARCH 51500 Check 5 false false false false false false Part I, Line 2 - Grantmakers Explanation For Monitoring Use of Funds Outside US Mid year and final reports are required as well as a report showing how the funds were used. Part I, Line 3f - Method of Accounting Grantee provides report. false EVENTS 590720 590720 293916 590720 590720 293916 293916 296804 true Doheny Eye Institute PO Box 86228 Los Angeles CA 90086 952916590 50000 0 GLAUCOMA RESEARCH GLAUCOMA REASERCH & EDUCATION 55 STEVENSON ST SAN FRANCISCO CA 94105 943208182 350000 0 GLAUCOMA RESEARCH MEDICAL COLLEGE OF WISCONSIN 925 N 87TH ST MILWAUKEE WI 53226 390806261 50000 0 GLAUCOMA RESEARCH STANFORD UNIVERSITY PO Box 44253 San Francisco CA 94144 941156365 150000 0 GLAUCOMA RESEARCH UC DAVIS PO Box 989062 West Sacramento CA 95798 946036494 150000 0 GLAUCOMA RESEARCH UC SAN DIEGO 9500 GILMAN DR MC 0009 LA JOLLA CA 92093 952872494 150000 0 GLAUCOMA RESEARCH UC SAN FRANCISCO PO Box 748872 Los Angeles CA 90074 946036493 150000 0 GLAUCOMA RESEARCH UNIVERSITY OF IOWA 375 Newton Rd IOWA CITY IA 52242 426004813 46830 0 GLAUCOMA RESEARCH University of North Texas 3500 Camp Bowie Blvd Fort Worth TX 76107 756064033 100000 0 GLAUCOMA RESEARCH VANDERBUILT EYE INSTITUTE 2215B Garland Ave NASHVILLE TN 37232 352528741 50000 0 GLAUCOMA RESEARCH 10 0 X X X X X false false false false false false false false false false NANCY GRAYDON E.D. DEVEL. & COO 212800 9531 222331 THOMAS M BRUNNER President & CEO 241697 12085 253782 X 9 39562 FMV false true false Form 990, Part VI, Line 11b: Form 990 Review Process STAFF REVIEW, COPY EMAILED TO BOARD FOR REVIEW/COMMENTS Form 990, Part VI, Line 12c: Explanation of Monitoring and Enforcement of Conflicts COMPLIANCE FORMS SENT EVERY JULY Form 990, Part VI, Line 15a: Compensation Review & Approval Process - CEO, Top Management Performance review by Board & Compensation Committee. Compensation Committee uses Salary Surveys and approves CEO compensation at Boards direction. Form 990, Part VI, Line 15b: Compensation Review and Approval Process for Officers and Key Employees Annual review by supervisor and approval by next level manager with use of comparability data Form 990, Part VI, Line 19: Other Organization Documents Publicly Available UPON REQUEST Other Changes In Net Assets Or Fund Balances - Other Increases CHANGE IN VALUE CHARITABLE TRUST = $10075